Name | Date | Size | #Lines | LOC | ||
---|---|---|---|---|---|---|
.. | 15-Sep-2021 | - | ||||
Control/Concurrent/ | H | 15-Sep-2021 | - | 35 | 27 | |
Development/ | H | 15-Sep-2021 | - | 16,285 | 12,258 | |
Generics/SYB/ | H | 15-Sep-2021 | - | 125 | 65 |
Name | Date | Size | #Lines | LOC | ||
---|---|---|---|---|---|---|
.. | 15-Sep-2021 | - | ||||
Control/Concurrent/ | H | 15-Sep-2021 | - | 35 | 27 | |
Development/ | H | 15-Sep-2021 | - | 16,285 | 12,258 | |
Generics/SYB/ | H | 15-Sep-2021 | - | 125 | 65 |